StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health operating margin

Operating margin is operating income as a percentage of revenue.

Aspira Women's Health's operating margin for the twelve months ending Jun 30, 2026 was -4059.4%. For fiscal 2025 it was -2307.0%, against -406950.0% the year before. The highest annual figure on record is -21.7% in fiscal 2023.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-2307.0%+404643.0
FY2024Dec 31, 2024-406950.0%−406928.3
FY2023Dec 31, 2023-21.7%+358.8
FY2022Dec 31, 2022-380.5%+98.0
FY2021Dec 31, 2021-478.5%−91.9
FY2020Dec 31, 2020-386.6%−49.9
FY2019Dec 31, 2019-336.7%+34.5
FY2018Dec 31, 2018-371.2%−36.7
FY2017Dec 31, 2017-334.5%+231.5
FY2016Dec 31, 2016-566.0%+318.2
FY2015Dec 31, 2015-884.2%−122.2
FY2014Dec 31, 2014-762.0%−416.6
FY2013Dec 31, 2013-345.4%+104.2
FY2012Dec 31, 2012-449.6%+467.8
FY2011Dec 31, 2011-917.4%+325.4
FY2010Dec 31, 2010-1242.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-10794.1%−9723.1
Q1 FY2026Mar 31, 2026-6884.4%−6718.5
Q4 FY2025Dec 31, 2025-4012.5%−3831.2
Q3 FY2025Sep 30, 2025-1774.2%−1555.4
Q2 FY2025Jun 30, 2025-1071.0%−1065.8
Q3 FY2024Sep 30, 2024-165.9%+19.8
Q2 FY2024Jun 30, 2024-181.3%−7.8
Q1 FY2024Mar 31, 2024-218.8%+52.4
Q4 FY2023Dec 31, 2023-5.2%+231.3
Q3 FY2023Sep 30, 2023-185.7%+228.4
Q2 FY2023Jun 30, 2023-173.5%+224.4
Q1 FY2023Mar 31, 2023-271.2%+217.3
Q4 FY2022Dec 31, 2022-236.5%+246.8
Q3 FY2022Sep 30, 2022-414.1%+167.6
Q2 FY2022Jun 30, 2022-397.9%+50.8
Q1 FY2022Mar 31, 2022-488.5%−95.0
Q4 FY2021Dec 31, 2021-483.3%−63.3
Q3 FY2021Sep 30, 2021-581.7%−236.2
Q2 FY2021Jun 30, 2021-448.7%+64.2
Q1 FY2021Mar 31, 2021-393.4%−82.0
Q4 FY2020Dec 31, 2020-420.1%−159.8
Q3 FY2020Sep 30, 2020-345.5%−45.9
Q2 FY2020Jun 30, 2020-512.9%−135.9
Q1 FY2020Mar 31, 2020-311.5%+151.7
Q4 FY2019Dec 31, 2019-260.2%+46.0
Q3 FY2019Sep 30, 2019-299.6%+41.9
Q2 FY2019Jun 30, 2019-377.0%+51.1
Q1 FY2019Mar 31, 2019-463.1%−26.3
Q4 FY2018Dec 31, 2018-306.3%+62.1
Q3 FY2018Sep 30, 2018-341.5%+16.0
Q2 FY2018Jun 30, 2018-428.1%−166.9
Q1 FY2018Mar 31, 2018-436.8%−71.0
Q4 FY2017Dec 31, 2017-368.4%−16.6
Q3 FY2017Sep 30, 2017-357.5%+198.7
Q2 FY2017Jun 30, 2017-261.2%–
Q1 FY2017Mar 31, 2017-365.8%–
Q4 FY2016Dec 31, 2016-351.8%–
Q3 FY2016Sep 30, 2016-556.2%–

More Aspira Women's Health figures

See a number that looks wrong?